| Tag | Content |
|---|
EnhancerAtlas ID | HS154-09903 |
Organism | Homo sapiens |
Tissue/cell | Osteoblast |
Coordinate | chr17:74510980-74512840 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Nr2f6(var.2) | MA0728.1 | chr17:74511090-74511105 | GAGGTCAGGAGTTCA | + | 6.22 | | Sox3 | MA0514.1 | chr17:74512315-74512325 | CCTTTGTTTT | + | 6.02 | | Zfx | MA0146.2 | chr17:74512576-74512590 | CCCGCCTCGGCCTC | + | 6.01 |
|
| | Number of super-enhancer constituents: 8 | ID | Coordinate | Tissue/cell |
| SE_03051 | chr17:74511107-74512036 | Bladder | | SE_09479 | chr17:74510785-74512354 | CD14 | | SE_11207 | chr17:74510641-74512778 | CD20 | | SE_20219 | chr17:74508830-74514648 | CD56 | | SE_22949 | chr17:74508579-74514665 | CD8_primiary | | SE_41105 | chr17:74511151-74512154 | Left_Ventricle | | SE_48771 | chr17:74511207-74512242 | Right_Atrium | | SE_62418 | chr17:74475150-74527312 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr17 | 74511165 | 74512553 | | chr17 | 74511289 | 74512094 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH17I076513 | chr17 | 74509114 | 74514557 |
|
Enhancer Sequence | GACTCTGTCT CAAAAAAAAA AAAAAAAAAA AAAGAGAGAG AGATGGCCGG GCGCGGTGGC 60
TCACACCTGT AATCCCAGCA TTTTGGGAGG CTGAGGTGGG TGGATCACTG GAGGTCAGGA 120
GTTCAAGACC AGCCTGACCA ACATGGTGAA ACCCCGTTTC TACTATAAAT ACAAAAATTA 180
GCTGGGTGTG GTGGCTCGCC CTGTAGTCCC AGCTACTCAG GAGGCTGAGG CAGGAGAATC 240
ACTTGAACCT GGGAGGCAGA GTGCAGTGAG CTGAGATCAT GCCACTGCAC ACCAGCCTGG 300
GCTATAGAGT GAGACTCTGT CTCACACACA CACACACAAA AAGAAGGCGA GAAGGGGAGC 360
CGGGGGAGAA ATGAGCCTGG AAAGATGGCC CGGGCCAAAT CAGGCGGGCT GGGGAGCCAG 420
GCCAGGACTC TGCTTTCTGT TTGGCTGTGA CTTCAGTAAG CTAGGGCAGG GTTTTGATGG 480
GCCAGGGAGG AGTCCACGCG ATCTGATTCA CACGATAAAA GCATTTCCTG GGCCCTGAGT 540
GGAGACCACA ACGTGGGAGG GCAGAGCGGA GGCCGACGAC TGGGAGGAGG CTTTGCAGTC 600
GCCGGGCGAG ACGATGGCTT TCTTTCCTGG CTCATTTCAC ACTAAACTGG GGACCAGCCA 660
GAAAGCCTTG GGAACTTGTC AGACCCACAT ACGCTGCCAC TGAGTCAACT GCTACTATCA 720
TCCCTGTGTG ACCTGAACCG AAACCCACTC ACTTGCGAAA CTGCTGGAGG CTTCTTCACT 780
AAAACCCATA TGCATGCTAA GATCCTGGCG TAACATAAAA TGTCATGTGC GTGTGCCGCG 840
TAAAATGTGC GTGTGCACAG GAAAACCACT GCCAGTATTT ACAGCAAAAC ACTCACAGTG 900
ACTCTCGGGT GGAGGGACCA CAGGGGACTT TTATTGTCAC AGCCCTGACT TCTGTCCTGC 960
TTCAGACCAG ACTCTCCAAC CACTTCCTGG ACACCTCCCT TTGTGCTTTT CTTTCCCCCT 1020
CAAATTTCCT GCAATGTTTT TTTTTTTTTT TTCGAGACAG AGTCTTGCTC TGTGACCCAG 1080
GCTGGAGTGC AGTGGTGTGA TCTCGGCTCA CTGCAACCTT CGCCCCTGGG TTTTTAAGTA 1140
ATTCTCCTAC CTCAGTCTCC TGAGTAGCTG GGATTACTGG CGCCTGCCAC CACGCCCAGC 1200
TAATTTTTGT ATTTTTAGTA GAGATGGGGT TTCACCATGT TGTCCAGGCT GGTCTCGAAC 1260
TCCTGACCTT GTGATCCGCC CGCCTTGCCC TCCTGAAGTG CTGGGATTAC AGGCCTGAGC 1320
CACCGCACCC GGCTGCCTTT GTTTTTGTTT TTGTTTTTGT TGTTGTTGTT TGAGACGGAG 1380
TCTCGCTCTG TTACCCAGGC CGGAGTGCAT GGTGCGATCT CGGCTCACTG CAACCTCCGC 1440
CTCCTGGGTT CAAGCGATTC TCCTGCCTCA GCCTCCCGAG TAGCTGGGAC TATAGCCACT 1500
TGCCACCATA CCCAGCTAAT TTTTGTATTT TTAGTAGAGA CAGGGTTTCA CCATATTGGC 1560
CAGGCTGGTC TCGAACCCCC GACCTCAGGT GATCCGCCCG CCTCGGCCTC CCAAAGTGCT 1620
GGGATTACAG GCGTGAGCCA CTGCACCTGG TCTGTTGTTT TTTTTTTAAA TTTTCTTTTT 1680
TTCACTCTCG CTGTCATCTT ATACATATTG CCTTTGTAAT CATATAGAAT CCCCAGGAAT 1740
GCTACTTCAA AAACTATGTA TAAGGCCAGG TACCGTGGTG TATGTACACC TGTAGTCTCA 1800
GCTACTCAGG AGGCTGAGGT GGGAGGATGG CTGAGCCCTG GAGGTCAAGG CTGCAGTGAG 1860
|
